SCHEMBL1978775

SCHEMBL1978775

CC(=O)C(C)(CBr)c1ccc(Cl)c(Cl)c1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TSHR P16473 3/20 0.41
SSTR4 P31391 1/20 0.39
HDAC3 O15379 2/20 0.38
HDAC1 Q13547 2/20 0.38
HDAC2 Q92769 2/20 0.38
HDAC6 Q9UBN7 2/20 0.38
CYP2C19 P33261 1/20 0.38
POLB P06746 1/20 0.37
CYP3A4 P08684 1/20 0.36
TACR2 P21452 1/20 0.35
TACR1 P25103 1/20 0.35
TACR3 P29371 1/20 0.35
KIF11 P52732 1/20 0.35
HDAC4 P56524 1/20 0.35
HDAC7 Q8WUI4 1/20 0.35
HDAC10 Q969S8 1/20 0.35
HDAC11 Q96DB2 1/20 0.35
HDAC8 Q9BY41 1/20 0.35
HDAC9 Q9UKV0 1/20 0.35
HDAC5 Q9UQL6 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Bromide SCHEMBL1977413 0.82 KIF11 (0.40) TSHRSSTR4HDAC3HDAC1HDAC2
SCHEMBL3406125 0.81 MEN1 (0.45) TSHRCYP2C19POLBCYP3A4KDM4E
SCHEMBL602699 0.77 TSHR (0.48) TSHRSSTR4HDAC3HDAC1HDAC2
SCHEMBL406254 0.75 TSHR (0.47) TSHRSSTR4HDAC3HDAC1HDAC2
SCHEMBL5796567 0.75 TSHR (0.42) TSHRSSTR4HDAC3HDAC1HDAC2
SCHEMBL604852 0.75 TSHR (0.42) TSHRSSTR4HDAC3HDAC1HDAC2
SCHEMBL14862611 0.74 L3MBTL1 (0.43) TSHRCYP2C19POLBCYP3A4KIF11
SCHEMBL296610 0.74 SSTR4 (0.40) TSHRSSTR4HDAC3HDAC1HDAC2
SCHEMBL1979360 0.71 BACE1 (0.39)
SCHEMBL4026261 0.70 TSHR (0.41) TSHRSSTR4HDAC3HDAC1HDAC2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2509960-A1 TGR5 AGONISTS Exelixis, Inc. (US) 2012-10-17 EP disclosed
EP-2396304-A1 TRIAZOLE AND IMIDAZOLE DERIVATIVES FOR USE AS TGR5 AGONISTS IN THE TREATMENT OF DIABETES AND OBESITY Exelixis, Inc. (US) 2011-12-21 EP disclosed
WO-2011071565-A1 TGR5 AGONISTS EXELIXIS, INC. (US) 2011-06-16 WO disclosed
WO-2010093845-A1 TRIAZOLE AND IMIDAZOLE DERIVATIVES FOR USE AS TGR5 AGONISTS IN THE TREATMENT OF DIABETES AND OBESITY EXELIXIS, INC. (US) 2010-08-19 WO disclosed